CSPC：SYH2059 has received its first clinical trial approval.
CSPC：SYS6055 has received its first clinical trial approval.
Biokin：BL-B01D1 has been formally accepted for review.
BrightGene：BGM0504 has been formally accepted for review.
Alphamab Oncology:Anbenitamab is planned to be submitted for marketing approval.
Akeso：Gumokimab was approved
MSD：ENFLONSIAClesrovimab approved for marketing in China.
How much does SPINRAZA (Nusinersen Sodium Injection) Cost& price without insurance in China?
How much does URECE (Dotinurad Tablets) Cost& price without insurance in China?
How much does EYLEA (Aflibercept Intravitreal Solution) Cost& price without insurance in China?
